Stiripentol in childhood partial epilepsy: Randomized placebo-controlled trial with enrichment and withdrawal design

Journal of Child Neurology

Volumn 21, Issue 6, 2006, Pages 496-502

  Chiron, Catherine ^a,b   Tonnelier, Sylvie ^c,d   Rey, Elisabeth ^c,d   Brunet, Marie Lucie ^e   Tran, Agnes ^c,d   d'Athis, Philppe ^c,d   Vincent, Jean ^f   Dulac, Olivier ^a,b   Pons, Gerard ^c,d  

^a INSERM   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL SAINT VINCENT DE PAUL   (France)

^e Pharmacy Department   (France)

^f Service de Pharmacologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; CLOBAZAM; CLONAZEPAM; PLACEBO; STIRIPENTOL; VIGABATRIN;

ABDOMINAL PAIN; ADD ON THERAPY; ARTICLE; ATAXIA; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPLOPIA; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; EXPERIMENTAL DESIGN; FEMALE; FOCAL EPILEPSY; FREQUENCY ANALYSIS; HUMAN; INTELLECTUAL IMPAIRMENT; MALE; METHODOLOGY; NAUSEA; NEUROTOXICITY; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SINGLE BLIND PROCEDURE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; DIOXOLANES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; TREATMENT OUTCOME; WITHHOLDING TREATMENT;

EID: 33645509617     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.2310/7010.2006.00129     Document Type: Article

References (15)

1. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989;30:389-399.
2. Gram L: Tiagabine: A novel drug with a GABAergic mechanism of action. Epilepsia 1994;35(Suppl):S85-S87.
3. Chiron C, Dulac O, Gram L: Vigabatrin withdrawal randomized study in children. Epilepsy Res 1996;25:209-215.
4. Tran A, Vauzelle-Kervroedan F, Rey E, et al: Effect of stiripentol on carbamazepine plasma concentration and metabolism in epileptic children. Eur J Clin Pharmacol 1996;50:497-500.
5. Chiron C, Marchand MC, Tran A, et al: Stiripentol in severe myoclonic epilepsy in infancy: A randomised placebo-controlled syndrome-dedicated trial. STICLO Study Group. Lancet 2000;356:1638-1642.
6. Perez J, Chiron C, Musial C, et al: Stiripentol: Efficacy and tolerability in children with epilepsy. Epilepsia 1999;40:1618-1626.
7. Motte J, Trevathan E, Arvidsson JF, et al: Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med 1997;337:1807-1812.
8. Duchowny M, Pellock JM, Graf WD, et al: A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group. Neurology 1999;53:1724-1731.
9. Sachdeo RC, Glauser TA, Ritter F, et al: A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Neurology 1999;52:1882-1887.
10. Elterman RD, Glauser TA, Wyllie E, et al: A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group. Neurology 1999;52:1338-1344.
11. Appleton R, Fichtner K, LaMoreaux L, et al: Gabapentin as add-on therapy in children with refractory partial seizures: A 12-week, multicentre, double-blind, placebo-controlled study Gabapentin Paediatric Study Group. Epilepsia 1999;40:1147-1154.
12. Glauser TA, Nigro M, Sachdeo R, et al: Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. Neurology 2000;54:2237-2244.
13. Schwabe S: Monotherapy comparative trials: Placebos and suboptimal comparators. Epilepsy Res 2001;45:93-96.
14. French JA: Proof of efficacy trials: Endpoints. Epilepsy Res 2001;45:53-56.
15. Novak G, Maytal J, Alshansky A, Ascher C: Risk factors for status epilepticus in children with symptomatic epilepsy. Neurology 1997;49:533-537.